Tonic App
Tonic App is a mobile platform designed for doctors by doctors, aiming to simplify medical practice through technology. It offers an intelligent virtual medical assistant, certified calculators and scales, clinical decision trees, drug information, medical job listings, and a weekly healthcare news digest. The app is a CE-marked medical device and is accredited by the European Accreditation Council in CME. Tonic App supports various aspects of a doctor's workflow, from diagnosis and treatment to administrative tasks and professional development. The company also offers services to pharmaceutical and medtech companies for market access, medical affairs, and product launch, utilizing real-world data and evidence to understand HCP engagement and digital journeys.
Tonic App
Tonic App is a mobile platform designed for doctors by doctors, aiming to simplify medical practice through technology. It offers an intelligent virtual medical assistant, certified calculators and scales, clinical decision trees, drug information, medical job listings, and a weekly healthcare news digest. The app is a CE-marked medical device and is accredited by the European Accreditation Council in CME. Tonic App supports various aspects of a doctor's workflow, from diagnosis and treatment to administrative tasks and professional development. The company also offers services to pharmaceutical and medtech companies for market access, medical affairs, and product launch, utilizing real-world data and evidence to understand HCP engagement and digital journeys.
TL;DR
Headquarters: Porto, Portugal
Founded: 2016
Product: CE‑marked mobile app for clinicians (clinical decision tools, content aggregation, team collaboration)
Latest funding: Series A, Mar 26, 2024 (~€10.85M)
Employees (reported): 53
Company Overview
Problem Domain
Clinician workflow efficiency, evidence‑based decision support, medical education/CME, HCP engagement analytics for life‑science companies.
Founded
2016
Industry
Healthtech / Medical software
Funding Track Record
€10.85M
Round reported as enabling expansion into the UK and Germany.
Investor Signal
“Participating investors include BlueCrow Capital, Iberis Capital, Vesalius Biocapital Partners, Shilling VC, Portugal Ventures, Armilar Venture Partners, FSNB Health & Care, TheVentureCity”